Skip to main content
Equibles

Murdo Gordon

Amgen Inc (AMGN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Amgen Inc publishes a filing, an earnings call transcript or a press release.

Get AMGN alerts

About Murdo Gordon

The proxy statement of Amgen Inc reports total compensation of $8,473,500 for Murdo Gordon in fiscal 2024, including a base salary of $1,197,268. Disclosed compensation is on record for 3 fiscal years. Murdo Gordon has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Amgen Inc on September 6, 2026. Amgen Inc is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Amgen Inc includes Robert Bradway (CEO), David W. Meline (CFO), Thomas Dittrich (CFO) and 7 others.

Murdo Gordon on recent calls

“We've got a nice story brewing at Amgen given that we have a set of prioritized growth drivers, three large products with Repatha Avenity Test Spire, our innovative oncology portfolio, our rare disease portfolio, and, of course, our biosimilars.”
Other, Goldman Sachs 47th Annual Global Healthcare Conference ·
“I'm pleased with our performance in the first quarter. Strong execution resulted in sales growth of 22% year-over-year, with robust volume growth across the four therapeutic pillars of our business.”
CFO, Amgen Inc Q1 FY2024 Earnings Call ·

Affiliation history

  • Amgen Inc (AMGN)

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 7, 2026

Company network

Leadership on record at Amgen Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Amgen Inc (AMGN) $1,197,268 $8,473,500
2023 Amgen Inc (AMGN) $1,144,623 $8,242,811
2022 Amgen Inc (AMGN) $1,103,277 $7,717,226

Recent activity